Alzheimer s & Dementia,
Год журнала:
2023,
Номер
19(12), С. 5447 - 5470
Опубликована: Май 22, 2023
Abstract
INTRODUCTION
A
hallmark
of
Alzheimer's
disease
(AD)
is
the
aggregation
proteins
(amyloid
beta
[A]
and
hyperphosphorylated
tau
[T])
in
brain,
making
cerebrospinal
fluid
(CSF)
particular
interest.
METHODS
We
conducted
a
CSF
proteome‐wide
analysis
among
participants
varying
AT
pathology
(
n
=
137
participants;
915
proteins)
with
nine
biomarkers
neurodegeneration
neuroinflammation.
RESULTS
identified
61
significantly
associated
category
P
<
5.46
×
10
−5
)
636
significant
protein‐biomarker
associations
6.07
−6
).
Proteins
from
glucose
carbon
metabolism
pathways
were
enriched
amyloid‐
tau‐associated
proteins,
including
malate
dehydrogenase
aldolase
A,
whose
replicated
an
independent
cohort
717).
metabolomics
association
succinylcarnitine
phosphorylated
other
biomarkers.
DISCUSSION
These
results
implicate
metabolic
dysregulation
increased
levels
amyloid
AD.
Highlights
Cerebrospinal
proteome
for
extracellular,
neuronal,
immune,
protein
processing.
Glucose/carbon
amyloid/tau‐associated
proteins.
Key
glucose/carbon
independently
replicated.
outperformed
omics
data
predicting
amyloid/tau
positivity.
succinylcarnitine–phosphorylated
association.
Brain,
Год журнала:
2017,
Номер
140(7), С. 1829 - 1850
Опубликована: Фев. 27, 2017
Sporadic
cerebral
amyloid
angiopathy
is
a
common,
well-defined
small
vessel
disease
and
largely
untreatable
cause
of
intracerebral
haemorrhage
contributor
to
age-related
cognitive
decline.
The
term
'cerebral
angiopathy'
now
encompasses
not
only
specific
cerebrovascular
pathological
finding,
but
also
different
clinical
syndromes
(both
acute
progressive),
brain
parenchymal
lesions
seen
on
neuroimaging
set
diagnostic
criteria—the
Boston
criteria,
which
have
resulted
in
increasingly
detected
during
life.
Over
the
past
few
years,
it
has
become
clear
that,
at
pathophysiological
level,
appears
be
part
protein
elimination
failure
that
this
dysfunction
feed-forward
process,
potentially
leads
worsening
vascular
amyloid-β
accumulation,
activation
injury
pathways
impaired
physiology.
From
standpoint,
characterized
by
individual
focal
(microbleeds,
cortical
superficial
siderosis,
microinfarcts)
large-scale
alterations
(white
matter
hyperintensities,
structural
connectivity,
thickness),
both
subcortical.
This
review
provides
an
interdisciplinary
critical
outlook
various
emerging
changing
concepts
field,
illustrating
mechanisms
associated
with
pathology
neurological
dysfunction.
Journal of Clinical Medicine,
Год журнала:
2019,
Номер
8(5), С. 651 - 651
Опубликована: Май 10, 2019
Alzheimer's
disease
(AD)
is
the
most
prevalent
form
of
dementia.
Despite
decades
research
following
several
theoretical
and
clinical
lines,
all
existing
treatments
for
disorder
are
purely
symptomatic.
AD
has
traditionally
been
focused
on
neuronal
glial
dysfunction.
Although
there
a
wealth
evidence
pointing
to
significant
vascular
component
in
disease,
this
angle
relatively
poorly
explored.
In
review,
we
consider
various
aspects
dysfunction
AD,
which
impact
brain
metabolism
homeostasis
clearance
β-amyloid
other
toxic
metabolites.
This
may
potentially
precede
onset
hallmark
pathophysiological
cognitive
symptoms
disease.
Pathological
changes
vessel
haemodynamics,
angiogenesis,
cell
function,
coverage,
blood-brain
barrier
permeability
immune
migration
be
related
amyloid
toxicity,
oxidative
stress
apolipoprotein
E
(APOE)
genotype.
These
deficits
turn
contribute
parenchymal
deposition,
neurotoxicity,
activation
metabolic
multiple
types.
A
vicious
feedback
cycle
ensues,
with
progressively
worsening
pathology
through
course
Thus,
better
appreciation
importance
open
new
avenues
therapy.
Acta Neuropathologica,
Год журнала:
2018,
Номер
136(5), С. 663 - 689
Опубликована: Окт. 22, 2018
The
dominant
hypothesis
of
Alzheimer's
disease
(AD)
aetiology,
the
neuropathological
guidelines
for
diagnosing
AD
and
majority
high-profile
therapeutic
efforts,
in
both
research
clinical
practice,
have
been
built
around
one
possible
causal
factor,
amyloid-β
(Aβ).
However,
link
between
Aβ
remains
unproven.
Here,
context
a
detailed
assessment
historical
contemporary
studies,
we
raise
critical
questions
regarding
role
definition,
diagnosis
aetiology
AD.
We
illustrate
that
holistic
view
available
data
does
not
support
an
unequivocal
conclusion
has
central
or
unique
Instead,
suggest
alternative
views
are
potentially
valid,
at
this
time.
propose
unbiased
way
forward
field,
beyond
current
Aβ-centric
approach,
without
excluding
Aβ,
is
required
to
come
accurate
understanding
dementia
and,
ultimately,
effective
treatment.
Frontiers in Neuroscience,
Год журнала:
2020,
Номер
14
Опубликована: Апрель 29, 2020
The
neurovascular
unit
(NVU),
comprised
of
vascular
cells,
glial
cells
and
neurons,
is
the
minimal
functional
brain.
NVU
maintains
integrity
blood-brain
barrier
(BBB)
regulates
supply
cerebral
blood
flow
(CBF),
both
which
are
keys
to
maintaining
normal
brain
function.
BBB
dysfunction
a
decreased
CBF
early
pathophysiological
changes
in
neurodegenerative
disorders,
such
as
Alzheimer's
disease
(AD),
Parkinson's
(PD),
amyotrophic
lateral
sclerosis
(ALS).
In
this
review,
we
primarily
focus
on
AD
much
research
has
been
performed
connection
between
AD.
We
also
discuss
role
mechanisms
PD
ALS.
As
most
diseases
difficult
treat,
several
potential
drug
targets
that
may
inform
novel
vascular-targeted
therapies
for
AD,
International Journal of Molecular Sciences,
Год журнала:
2017,
Номер
18(8), С. 1813 - 1813
Опубликована: Авг. 21, 2017
γ-aminobutyric
acid
(GABA)
is
the
primary
inhibitory
neurotransmitter
in
vertebrate
brain.
In
past,
there
has
been
a
major
research
drive
focused
on
dysfunction
of
glutamatergic
and
cholinergic
systems
Alzheimer's
disease
(AD).
However,
now
growing
evidence
support
GABAergic
contribution
to
pathogenesis
this
neurodegenerative
disease.
Previous
studies
paint
complex,
convoluted
often
inconsistent
picture
AD-associated
remodeling.
Given
importance
system
neuronal
function
homeostasis,
maintenance
excitatory/inhibitory
balance,
processes
learning
memory,
such
changes
could
be
an
important
factor
both
early
later
stages
AD
pathogenesis.
limited
scope
currently
available
therapies
modifying
course
disease,
better
understanding
remodeling
open
up
innovative
novel
therapeutic
opportunities.
Frontiers in Cellular Neuroscience,
Год журнала:
2019,
Номер
13
Опубликована: Фев. 26, 2019
Infection
with
herpes
simplex
virus
type
1
(HSV-1)
is
highly
prevalent
in
the
human
population
most
of
infected
asymptomatic.
Importantly,
HSV-1
can
infect
brain
by
reaching
neurons
trigeminal
ganglia
and
without
evident
clinical
symptoms.
Once
brain,
either
reside
a
quiescent
latent
state
this
tissue,
or
eventually
actively
lead
to
severe
acute
necrotizing
encephalitis,
which
characterized
exacerbated
neuroinflammation
prolonged
neuroimmune
activation
producing
life-threatening
disease.
Although
encephalitis
be
treated
antivirals
that
limit
replication,
neurological
sequelae
are
common
will
nevertheless
remain
tissue.
there
accumulating
evidence
suggests
infection
both
symptomatic
asymptomatic
individuals
multiple
neurodegenerative
disorders.
Here,
we
review
discuss
chronic
specific
regions
how
may
affect
neuron
cognitive
functions
host.
We
potential
cellular
molecular
mechanisms
leading
neurodegeneration,
such
as
protein
aggregation,
dysregulation
autophagy,
oxidative
cell
damage
apoptosis,
among
others.
Furthermore,
impact
over
inflammation
its
relationship
diseases.
Journal of Neurochemistry,
Год журнала:
2018,
Номер
146(6), С. 649 - 669
Опубликована: Апрель 12, 2018
Glutamatergic
and
cholinergic
dysfunction
are
well-attested
features
of
Alzheimer's
disease
(AD),
progressing
with
other
pathological
indices
the
disorder
exacerbating
neuronal
network
dysfunction.
However,
relatively
little
attention
has
been
paid
to
inhibitory
component
excitatory/inhibitory
(E/I)
network,
particularly
in
gamma-aminobutyric
acid
(GABA)
signaling
system.
There
is
growing
evidence
support
GABAergic
remodeling
AD
brain,
potentially
beginning
early
stages
pathogenesis,
this
could
thus
be
a
valid
molecular
target
for
drug
development
pharmacological
therapies.
Several
drugs
have
tested
efficacy
attenuating
or
reversing
various
symptoms
AD,
represent
novel
path
by
which
we
might
address
need
more
effective
benign